Search research articles
Contact Us
Filters
Showing results (81-90 of 119) with videos related to
Page
of 12
Sort By:
Peptides
|
May 1, 1989
Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat
P Romualdi, J G Rosenberger, L Gozzini, et al.
Life Sciences
|
June 15, 1975
A peptide-like substance from pituitary that acts like morphine. I. Isolation
H Teschemacher, K E Opheim, B M Cox, et al.
Life Sciences
|
June 15, 1975
A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties
B M Cox, K E Opheim, H Teschemacher, et al.
Life Sciences
|
January 1, 1994
Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain
B Búzás, S Izenwasser, P S Portoghese, et al.
Journal of Chromatography
|
June 1, 1978
Rapid purification of beta-endorphin by high-performance liquid chromatography
S Gentleman, L I Lowney, B M Cox, et al.
European Journal of Pharmacology
|
February 28, 2001
Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine
P Romualdi, C D'Addario, S Ferri, et al.
Molecular Pharmacology
|
August 1, 1995
Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells
T Tang, J G Kiang, T E Côté, et al.
Brain Research. Molecular Brain Research
|
August 1, 1996
Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen
P Romualdi, A Donatini, S Izenwasser, et al.
Neuroscience Letters
|
November 30, 1982
Distribution of immunoreactive dynorphin in discrete brain nuclei; comparison with vasopressin
C J Molineaux, G Feuerstein, A L Faden, et al.
Neuropharmacology
|
November 1, 1990
Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways
S Izenwasser, L L Werling, J G Rosenberger, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 119) with videos related to
Sort By:
Page
of 12
Peptides
|
May 1, 1989
Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat
P Romualdi, J G Rosenberger, L Gozzini, et al.
Life Sciences
|
June 15, 1975
A peptide-like substance from pituitary that acts like morphine. I. Isolation
H Teschemacher, K E Opheim, B M Cox, et al.
Life Sciences
|
June 15, 1975
A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties
B M Cox, K E Opheim, H Teschemacher, et al.
Life Sciences
|
January 1, 1994
Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain
B Búzás, S Izenwasser, P S Portoghese, et al.
Journal of Chromatography
|
June 1, 1978
Rapid purification of beta-endorphin by high-performance liquid chromatography
S Gentleman, L I Lowney, B M Cox, et al.
European Journal of Pharmacology
|
February 28, 2001
Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine
P Romualdi, C D'Addario, S Ferri, et al.
Molecular Pharmacology
|
August 1, 1995
Antisense oligodeoxynucleotide to the Gi2 protein alpha subunit sequence inhibits an opioid-induced increase in the intracellular free calcium concentration in ND8-47 neuroblastoma x dorsal root ganglion hybrid cells
T Tang, J G Kiang, T E Côté, et al.
Brain Research. Molecular Brain Research
|
August 1, 1996
Chronic intracerebroventricular cocaine differentially affects prodynorphin gene expression in rat hypothalamus and caudate-putamen
P Romualdi, A Donatini, S Izenwasser, et al.
Neuroscience Letters
|
November 30, 1982
Distribution of immunoreactive dynorphin in discrete brain nuclei; comparison with vasopressin
C J Molineaux, G Feuerstein, A L Faden, et al.
Neuropharmacology
|
November 1, 1990
Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways
S Izenwasser, L L Werling, J G Rosenberger, et al.
Page
of 12